MedPath

UNIVERSITAS MUHAMMADIYAH SEMARANG

🇮🇩Indonesia
Ownership
-
Established
1999-01-01
Employees
-
Market Cap
-
Website
http://unimus.ac.id

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Early Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Early Phase 1
1 (50.0%)
Not Applicable
1 (50.0%)

Butterfly Pea Flower (Clitoria Ternatea) for Adjuvant TB Treatment

Early Phase 1
Completed
Conditions
Tuberculosis (TB)
Tuberculosis Treatment Effectiveness
Interventions
Drug: Herbal medicine
Other: Tuberculosis (TB) treatment
First Posted Date
2025-01-27
Last Posted Date
2025-01-27
Lead Sponsor
Universitas Muhammadiyah Semarang
Target Recruit Count
28
Registration Number
NCT06794502
Locations
🇮🇩

West Kotawaringin Health Department, Pangkalan Bun, Central Kalimantan, Indonesia

🇮🇩

Mendawai Community Health Center, Pangkalan Bun, Central Kalimantan, Indonesia

Curcuma Extract Beneficial for Muscle Damage

Not Applicable
Completed
Conditions
Athletes Foot
First Posted Date
2020-06-19
Last Posted Date
2020-06-19
Lead Sponsor
Universitas Muhammadiyah Semarang
Target Recruit Count
20
Registration Number
NCT04439981
Locations
🇮🇩

Badan Pusat Pendidikan dan Pelatihan Olahraga Pelajar (BPPLOP) Semarang, Indonesia, Semarang, Provinsi, Indonesia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.